# Peptides Studied for Osteoporosis: The Trials | PepVault

Source: https://pepvault.app/conditions/osteoporosis

Last updated: 2026-11-19

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [By condition](https://pepvault.app/conditions) Osteoporosis

Peptides by condition · Muscles, bones, joints and skin

# Peptides studied for osteoporosis

Checked November 2026 against our study pages and the FDA labels [Published by PepVault](https://pepvault.app/guides/how-we-research)

Our library holds 15 study pages on osteoporosis: 15 in people (13 of them meta-analyses or randomized trials). They studied 3 compounds, with this many study pages each: Abaloparatide 8, Teriparatide 6 and MK-677 1.

## What the research on osteoporosis looks like

Osteoporosis is bone that has grown thin and weak, so it breaks more easily, most often in the spine, the hip and the wrist. It is most common in women after menopause, and men get it too. Most bone drugs slow the breakdown of old bone; the two peptides studied here, teriparatide and abaloparatide, copy parathyroid hormone and a close relative of it, and push the body to build new bone instead.

Osteoporosis trials measure bone mineral density (BMD) on a DXA scan, a low-dose X-ray of the spine and hip, and count new fractures, above all new spine fractures seen on X-ray, against placebo or another bone drug. A few take a small core of bone from the hip to look at it under a microscope.

A gain in bone density on a scan is not the same as fewer broken bones, so the trials that counted fractures carry the most weight. Check what came after the peptide: these drugs are given for a set time and then usually followed by another bone drug, and several of these studies report the two in sequence.

How many of the 15 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## The 15 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

1. ### [Abaloparatide](https://pepvault.app/peptides/abaloparatide)

   8 in people

   For osteoporosis, 8 of our study pages are filed under Abaloparatide: 2 meta-analyses, 5 randomized trials and 1 clinical trial in people. The largest in people enrolled 2,463 people and was published in 2016. They were published from 2016 to 2025, in Front Endocrinol (Lausanne), J Orthop Surg Res, JAMA, J Bone Joint Surg Am, Arch Osteoporos, J Clin Endocrinol Metab, Bone and J Bone Miner Res.

   FDA-approved, with a use tied to osteoporosis on its label: Tymlos (injection) for osteoporosis at high risk of fracture in women after menopause, and building bone density in men with osteoporosis at high risk of fracture.

   - Meta-analysis in people · 2025 [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
   - Meta-analysis in people · 2023 [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
   - Randomized trial in people · 2,463 people · 2016 [Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE](https://pepvault.app/research/abaloparatide-active-2016)
   - Randomized trial in people · 500 people · 2024 [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
   - Randomized trial in people · 2023 [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023)
   - Randomized trial in people · 2018 [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018)
   - Randomized trial in people · 2017 [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017)
   - Clinical trial in people · 23 people · 2021 [Abaloparatide: bone formation up on every surface tested at 3 months](https://pepvault.app/research/abaloparatide-dempster-2021)

   - [Tymlos, from its FDA label](https://pepvault.app/drugs/tymlos)
   - [Abaloparatide: legal and regulatory status](https://pepvault.app/peptides/abaloparatide/legal-status)
   - [Abaloparatide in the library](https://pepvault.app/peptides/abaloparatide)
   - [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
2. ### [Teriparatide](https://pepvault.app/peptides/teriparatide)

   6 in people

   For osteoporosis, 6 of our study pages are filed under Teriparatide: 1 meta-analysis, 4 randomized trials and 1 clinical trial in people. The largest in people pooled 6,680 people and was published in 2024. They were published from 2014 to 2024, in Arch Osteoporos, J Clin Endocrinol Metab, World Neurosurg and Lancet.

   FDA-approved, with a use tied to osteoporosis on its label: Forteo (injection) for osteoporosis at high risk of fracture in women after menopause and in men, and osteoporosis caused by long-term steroid treatment; Bonsity (injection) for osteoporosis at high risk of fracture in women after menopause and in men, and osteoporosis caused by long-term steroid treatment.

   - Meta-analysis in people · 6,680 people · 2024 [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
   - Randomized trial in people · 94 people · 2014 [Teriparatide plus denosumab: 12.9% spine BMD gain at 24 months](https://pepvault.app/research/teriparatide-data-extension-study-2014)
   - Randomized trial in people · 77 people · 2022 [Teriparatide: more bony union at 6 months than zoledronate after PLIF](https://pepvault.app/research/teriparatide-xiong-2022)
   - Randomized trial in people · 77 people · 2015 [Teriparatide then denosumab: spine density up 18.3% over 4 years](https://pepvault.app/research/teriparatide-data-switch-2015)
   - Randomized trial in people · 2018 [Teriparatide: fewer new vertebral fractures than risedronate in VERO](https://pepvault.app/research/teriparatide-vero-2018)
   - Clinical trial in people · 32 people · 2022 [Teriparatide then denosumab: 21.9% spine bone density gain](https://pepvault.app/research/teriparatide-shane-2022)

   - [Forteo, from its FDA label](https://pepvault.app/drugs/forteo)
   - [Teriparatide: legal and regulatory status](https://pepvault.app/peptides/teriparatide/legal-status)
   - [Teriparatide in the library](https://pepvault.app/peptides/teriparatide)
   - [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
3. ### [MK-677](https://pepvault.app/peptides/mk-677)

   1 in people

   For osteoporosis, 1 of our study pages is filed under MK-677: 1 randomized trial in people. It enrolled 292 people and was published in 2001, in J Clin Endocrinol Metab.

   MK-677 (ibutamoren) has no FDA-approved product: Drugs@FDA lists no application for it.

   - Randomized trial in people · 292 people · 2001 [MK-677 plus alendronate: 4.2% femoral neck BMD gain vs 2.5% alone](https://pepvault.app/research/mk-677-murphy-2001)

   - [MK-677: legal and regulatory status](https://pepvault.app/peptides/mk-677/legal-status)
   - [MK-677 in the library](https://pepvault.app/peptides/mk-677)
   - [MK-677 dose guide](https://pepvault.app/lab/dosage/mk-677)

## On osteoporosis

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)
- [Ipamorelin vs MK-677](https://pepvault.app/peptides/compare/ipamorelin-vs-mk-677)
- [MK-677 vs CJC-1295 no DAC](https://pepvault.app/peptides/compare/mk-677-vs-cjc-1295-no-dac)
- [HGH vs MK-677](https://pepvault.app/peptides/compare/hgh-vs-mk-677)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Related conditions

- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for skin wounds and ulcers](https://pepvault.app/conditions/wounds-and-ulcers)
- [Peptides studied for mitochondrial and muscle disease](https://pepvault.app/conditions/mitochondrial-disease)

### By goal

- [Peptides for injury recovery and healing](https://pepvault.app/peptides/for/injury-recovery)
- [Peptides for muscle growth](https://pepvault.app/peptides/for/muscle-growth)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## Side by side

For the 3 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

| Compound | In people | Animals or cells | Largest in people | FDA |
| --- | --- | --- | --- | --- |
| [Abaloparatide](https://pepvault.app/peptides/abaloparatide) | 8 | 0 | 2,463 | Approved, a use tied to it |
| [Teriparatide](https://pepvault.app/peptides/teriparatide) | 6 | 0 | 6,680 | Approved, a use tied to it |
| [MK-677](https://pepvault.app/peptides/mk-677) | 1 | 0 | 292 | Not approved |

## What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) This study covers men only. It compares the drugs by pooling separate studies rather than testing them side by side in a single trial.
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) The pool of studies was small, and every head-to-head trial was sponsored by the manufacturer. The fracture data were too limited to judge whether either drug prevents more fractures.
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024) The pooled trials differed from each other clinically, so the team used both fixed-effect and random-effect models. It covers only people who had not had a bisphosphonate before, so it doesn't speak to people switching from one.
- [Teriparatide plus denosumab: 12.9% spine BMD gain at 24 months](https://pepvault.app/research/teriparatide-data-extension-study-2014) This was a small trial that measured bone density and blood markers, not fractures, so it does not show whether the combination prevents more broken bones. It included only postmenopausal women with osteoporosis.
- [MK-677 plus alendronate: 4.2% femoral neck BMD gain vs 2.5% alone](https://pepvault.app/research/mk-677-murphy-2001) The extra bone density gain showed up at only one of four sites measured, and people taking MK-677 had side effects linked to higher growth hormone, though few quit because of them. The trial included only older women with postmenopausal osteoporosis, and bone marker results were for 12 months.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

## Related pages

- [Peptides studied for growth hormone deficiency 1 compound in common](https://pepvault.app/conditions/growth-hormone-deficiency)
- [Peptides studied for knee pain and osteoarthritis 3 studies](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for skin wounds and ulcers 10 studies](https://pepvault.app/conditions/wounds-and-ulcers)
- [Peptides studied for mitochondrial and muscle disease 8 studies](https://pepvault.app/conditions/mitochondrial-disease)

### By goal

- [Peptides for injury recovery and healing](https://pepvault.app/peptides/for/injury-recovery)
- [Peptides for muscle growth](https://pepvault.app/peptides/for/muscle-growth)

### Trial terms

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Phase 1, 2 and 3 trials](https://pepvault.app/glossary/clinical-trial-phases)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## Questions

### Which peptides have been studied for osteoporosis?

Our 15 study pages on osteoporosis are filed under 3 compounds, with this many each: Abaloparatide 8, Teriparatide 6 and MK-677 1. Abaloparatide has the most.

### Have any been tested in people with osteoporosis?

Yes: all 15 were in people, 13 of them meta-analyses or randomized trials (Abaloparatide, Teriparatide and MK-677). The largest pooled 6,680 people: “Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)” (2024).

### Is any peptide FDA-approved for osteoporosis?

Yes, with a use tied to osteoporosis on their FDA labels: Abaloparatide as Tymlos; Teriparatide as Forteo and Bonsity. 1 other compound here with an FDA record has no use tied to it.

### How large were the studies in people on osteoporosis?

Of the 15 in people, 9 give their size on our pages: 2 had 1,000 people or more, 2 had 100 to 999 and 5 had fewer than 100. The largest, a meta-analysis from 2024, pooled 6,680.

### What is the newest study on osteoporosis here?

Of our study pages on osteoporosis, the newest is “Abaloparatide, teriparatide beat other drugs on spine BMD in men”, a meta-analysis in people published in 2025.

## How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On osteoporosis

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)
- [Ipamorelin vs MK-677](https://pepvault.app/peptides/compare/ipamorelin-vs-mk-677)
- [MK-677 vs CJC-1295 no DAC](https://pepvault.app/peptides/compare/mk-677-vs-cjc-1295-no-dac)
- [HGH vs MK-677](https://pepvault.app/peptides/compare/hgh-vs-mk-677)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Related conditions

- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for skin wounds and ulcers](https://pepvault.app/conditions/wounds-and-ulcers)
- [Peptides studied for mitochondrial and muscle disease](https://pepvault.app/conditions/mitochondrial-disease)

### By goal

- [Peptides for injury recovery and healing](https://pepvault.app/peptides/for/injury-recovery)
- [Peptides for muscle growth](https://pepvault.app/peptides/for/muscle-growth)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## By condition

- [Every condition](https://pepvault.app/conditions)
- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for skin wounds and ulcers](https://pepvault.app/conditions/wounds-and-ulcers)
- [Peptides studied for mitochondrial and muscle disease](https://pepvault.app/conditions/mitochondrial-disease)

## The research

- [Studies, in plain English](https://pepvault.app/research)
- [The peptide reference library](https://pepvault.app/peptides)
- [Peptides by goal](https://pepvault.app/peptides/for)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
